President-elect Donald Trump's proposed tariffs on foreign imports could lead to higher costs for generic drugs, policy experts say. 

Cleveland Clinic London Hospital has launched the first phase of its central intravenous additive service unit for non-hazardous sterile compounds. 

NYC Hospitals + Health is rolling out a multimillion dollar upgrade to its medication management systems, aimed at improving efficiency and patient safety access across the network. 

GLP-1s and GLP-2s, or glucagon-like peptides, are both secreted from gut endocrine cells and promote nutrient absorption. As medications, they differ vastly. 

Endo USA has expanded its voluntary recall of clonazepam orally disintegrating tablets due to a mislabeling issue that could lead to patients accidentally ingesting the wrong dosage. 

Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22. 

Almost a year after receiving FDA approval, Florida's plan to import lower-cost prescription drugs from Canada remains mired in delays, KFF Health News reported Nov. 21.

Robert F. Kennedy Jr., who was recently nominated to lead HHS during Donald Trump's second presidency, has cast doubt on Ozempic's potential health effects.

New York state has introduced new regulations aimed at curbing the practices of pharmacy benefit managers, including divisions of CVS Health, Cigna Group and UnitedHealth Group, Bloomberg reported Nov. 20. 

Anil Ravandur has been named the new chief information officer and vice president of the office of information technology at the American Society of Health-System Pharmacists.